Can't I stop taking obeticholic acid once I take it?

Obeticholic acid is a drug used to treat primary biliary cholangitis (PBC). This disease is a chronic progressive disease that mainly manifests as inflammation and damage to the bile ducts in the liver, leading to the accumulation of bile in the liver, causing the gradual deterioration of liver function, and may eventually develop into cirrhosis. Although there is currently no cure for PBC, the use of obeticholic acid offers patients hope of relieving their symptoms and improving their quality of life.

Obeticholic acid, as an agonist of farnesoidX receptor (FXR), can effectively reduce the concentration of bile acids in the liver and reduce inflammation and fibrosis caused by cholestasis. Through this mechanism, the drug not only helps to improve liver function indicators, such as alkaline phosphatase, alanine aminotransferase, etc., but also delays the development of the disease and alleviates the patient's symptoms. Therefore, starting medication as early as possible is crucial to controlling the condition.

The use of obeticholic acid needs to be approached with caution regarding whether the drug can be discontinued. Once treatment is started, it is strongly recommended to continue taking the medication under the guidance of a doctor, as sudden discontinuation may lead to a sharp worsening of the condition. Although some patients may experience relief of symptoms after taking obeticholic acid, this does not mean the disease is cured or completely controlled. On the contrary, stopping the drug may allow bile to accumulate in the liver again, leading to increased inflammation and possibly even rapid progression to the cirrhosis stage.

During the treatment process, it is very important to regularly monitor liver function and disease changes to ensure the effectiveness and safety of the treatment. If the patient experiences discomfort or side effects while using obeticholic acid, he or she must communicate with the doctor in time, and the doctor may adjust the treatment plan according to the patient's specific condition.

Reference materials:https://my.clevelandclinic.org/health/diseases/17715-primary-biliary-cholangitis-pbc